These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

886 related items for PubMed ID: 19486920

  • 1. Nanotechnological applications for the treatment of neurodegenerative disorders.
    Modi G, Pillay V, Choonara YE, Ndesendo VM, du Toit LC, Naidoo D.
    Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
    [Abstract] [Full Text] [Related]

  • 2. Advances in the treatment of neurodegenerative disorders employing nanotechnology.
    Modi G, Pillay V, Choonara YE.
    Ann N Y Acad Sci; 2010 Jan; 1184():154-72. PubMed ID: 20146696
    [Abstract] [Full Text] [Related]

  • 3. Nanotherapeutics for Alzheimer's disease (AD): Past, present and future.
    Fazil M, Shadab, Baboota S, Sahni JK, Ali J.
    J Drug Target; 2012 Feb; 20(2):97-113. PubMed ID: 22023651
    [Abstract] [Full Text] [Related]

  • 4. Potential applications of nanotechnologies to Parkinson's disease therapy.
    Linazasoro G, Nanotechnologies for Neurodegenerative Diseases Study Group of the Basque Country (NANEDIS).
    Parkinsonism Relat Disord; 2008 Feb; 14(5):383-92. PubMed ID: 18329315
    [Abstract] [Full Text] [Related]

  • 5. Engineered nanoparticles as precise drug delivery systems.
    Yih TC, Al-Fandi M.
    J Cell Biochem; 2006 Apr 15; 97(6):1184-90. PubMed ID: 16440317
    [Abstract] [Full Text] [Related]

  • 6. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM, Amiji MM.
    Expert Opin Drug Deliv; 2009 Mar 15; 6(3):211-25. PubMed ID: 19290842
    [Abstract] [Full Text] [Related]

  • 7. Chapter 4 - Applications of nanotechnology in molecular imaging of the brain.
    McAteer MA, Choudhury RP.
    Prog Brain Res; 2009 Mar 15; 180():72-96. PubMed ID: 20302829
    [Abstract] [Full Text] [Related]

  • 8. Nanoparticles in medicine: therapeutic applications and developments.
    Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC.
    Clin Pharmacol Ther; 2008 May 15; 83(5):761-9. PubMed ID: 17957183
    [Abstract] [Full Text] [Related]

  • 9. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
    Wilson B, Samanta MK, Santhi K, Kumar KP, Paramakrishnan N, Suresh B.
    Brain Res; 2008 Mar 20; 1200():159-68. PubMed ID: 18291351
    [Abstract] [Full Text] [Related]

  • 10. Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
    Sahni JK, Doggui S, Ali J, Baboota S, Dao L, Ramassamy C.
    J Control Release; 2011 Jun 10; 152(2):208-31. PubMed ID: 21134407
    [Abstract] [Full Text] [Related]

  • 11. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier.
    Silva GA.
    Surg Neurol; 2007 Feb 10; 67(2):113-6. PubMed ID: 17254859
    [Abstract] [Full Text] [Related]

  • 12. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.
    Roney C, Kulkarni P, Arora V, Antich P, Bonte F, Wu A, Mallikarjuana NN, Manohar S, Liang HF, Kulkarni AR, Sung HW, Sairam M, Aminabhavi TM.
    J Control Release; 2005 Nov 28; 108(2-3):193-214. PubMed ID: 16246446
    [Abstract] [Full Text] [Related]

  • 13. Cerium oxide nanoparticles: a 'radical' approach to neurodegenerative disease treatment.
    Naz S, Beach J, Heckert B, Tummala T, Pashchenko O, Banerjee T, Santra S.
    Nanomedicine (Lond); 2017 Mar 28; 12(5):545-553. PubMed ID: 28181459
    [Abstract] [Full Text] [Related]

  • 14. Nanoparticles of biodegradable polymers for new-concept chemotherapy.
    Feng SS.
    Expert Rev Med Devices; 2004 Sep 28; 1(1):115-25. PubMed ID: 16293015
    [Abstract] [Full Text] [Related]

  • 15. Application of nanotechnology in biomedicine.
    Navalakhe RM, Nandedkar TD.
    Indian J Exp Biol; 2007 Feb 28; 45(2):160-5. PubMed ID: 17375555
    [Abstract] [Full Text] [Related]

  • 16. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.
    Rajpoot K.
    Curr Drug Targets; 2020 Feb 28; 21(8):819-836. PubMed ID: 31906836
    [Abstract] [Full Text] [Related]

  • 17. Nanotechnology for sensing, imaging, and treating cancer.
    Panchapakesan B, Wickstrom E.
    Surg Oncol Clin N Am; 2007 Apr 28; 16(2):293-305. PubMed ID: 17560513
    [Abstract] [Full Text] [Related]

  • 18. Advances in the treatment of neurodegenerative disorders employing nanoparticles.
    Spuch C, Saida O, Navarro C.
    Recent Pat Drug Deliv Formul; 2012 Apr 01; 6(1):2-18. PubMed ID: 22272933
    [Abstract] [Full Text] [Related]

  • 19. Chapter 5 - Development of iron chelator-nanoparticle conjugates as potential therapeutic agents for Alzheimer disease.
    Liu G, Men P, Perry G, Smith MA.
    Prog Brain Res; 2009 Apr 01; 180():97-108. PubMed ID: 20302830
    [Abstract] [Full Text] [Related]

  • 20. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL, Wu XY, Bendayan R.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):686-700. PubMed ID: 22100125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.